Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.245 USD | -0.62% | -4.46% | -40.02% |
04-30 | Wells Fargo Cuts Price Target on Accolade to $10 From $12, Maintains Equalweight Rating | MT |
04-26 | Morgan Stanley Trims Accolade's Price Target to $12 From $13, Maintains Equal Weight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.02% | 571M | |
+19.83% | 84.31B | |
-28.89% | 69.9B | |
+9.65% | 29.06B | |
-8.91% | 17.38B | |
+2.03% | 17.01B | |
+0.25% | 15.35B | |
+6.36% | 12.91B | |
+69.66% | 12.47B | |
+6.30% | 12.26B |
- Stock Market
- Equities
- ACCD Stock
- News Accolade, Inc.
- Accolade Reports Narrowing Net Loss in Fiscal Q2 as Sales Increase